BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ikari N, Serizawa A, Mitani S, Yamamoto M, Furukawa T. Near-Comprehensive Resequencing of Cancer-Associated Genes in Surgically Resected Metastatic Liver Tumors of Gastric Cancer. The American Journal of Pathology 2019;189:784-96. [DOI: 10.1016/j.ajpath.2018.12.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Miller JJ, Gaiddon C, Storr T. A balancing act: using small molecules for therapeutic intervention of the p53 pathway in cancer. Chem Soc Rev 2020;49:6995-7014. [DOI: 10.1039/d0cs00163e] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
2 Blanchet A, Bourgmayer A, Kurtz JE, Mellitzer G, Gaiddon C. Isoforms of the p53 Family and Gastric Cancer: A Ménage à Trois for an Unfinished Affair. Cancers (Basel) 2021;13:916. [PMID: 33671606 DOI: 10.3390/cancers13040916] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
3 Zhang Z, Zhao G, Jiang B, Li B, Wang Y. Clinicopathological features and differential diagnosis of gastrofibromatosis-like undifferentiated carcinoma. J Int Med Res 2020;48:300060520974463. [PMID: 33373269 DOI: 10.1177/0300060520974463] [Reference Citation Analysis]
4 Wood AC, Zhang Y, Mo Q, Cen L, Fontaine J, Hoffe SE, Frakes J, Dineen SP, Pimiento JM, Walko CM, Mehta R. Evaluation of Tumor DNA Sequencing Results in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma Stratified by TP53 Mutation Status. The Oncologist 2022. [DOI: 10.1093/oncolo/oyac018] [Reference Citation Analysis]
5 Zhao Y, Li J, Li D, Wang Z, Zhao J, Wu X, Sun Q, Lin PP, Plum P, Damanakis A, Gebauer F, Zhou M, Zhang Z, Schlösser H, Jauch KW, Nelson PJ, Bruns CJ. Tumour biology and multidisciplinary strategies of oligometastasis in gastrointestinal cancers.Semin Cancer Biol. 2020;60:334-343. [PMID: 31445220 DOI: 10.1016/j.semcancer.2019.08.026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
6 Aoki Y, Mizuma M, Hata T, Aoki T, Omori Y, Ono Y, Mizukami Y, Unno M, Furukawa T. Intraductal papillary neoplasms of the bile duct consist of two distinct types specifically associated with clinicopathological features and molecular phenotypes. J Pathol 2020;251:38-48. [PMID: 32100878 DOI: 10.1002/path.5398] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
7 Yamashita K, Hosoda K, Niihara M, Hiki N. History and emerging trends in chemotherapy for gastric cancer. Ann Gastroenterol Surg 2021;5:446-56. [PMID: 34337293 DOI: 10.1002/ags3.12439] [Reference Citation Analysis]
8 Yasufuku I, Saigo C, Kito Y, Yoshida K, Takeuchi T. Prognostic significance of LDL receptor-related protein 1B in patients with gastric cancer. J Mol Histol 2021;52:165-72. [PMID: 33389427 DOI: 10.1007/s10735-020-09932-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Liang L, Zhu JH, Chen G, Qin XG, Chen JQ. Prognostic Values for the mRNA Expression of the ADAMTS Family of Genes in Gastric Cancer. J Oncol 2020;2020:9431560. [PMID: 32884571 DOI: 10.1155/2020/9431560] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Jiang W, Xu Y, Chen X, Pan S, Zhu X. E26 transformation-specific variant 4 as a tumor promotor in human cancers through specific molecular mechanisms. Mol Ther Oncolytics 2021;22:518-27. [PMID: 34553037 DOI: 10.1016/j.omto.2021.07.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Moradi N, Ohadian Moghadam S, Heidarzadeh S. Application of next-generation sequencing in the diagnosis of gastric cancer. Scand J Gastroenterol 2022;:1-14. [PMID: 35293278 DOI: 10.1080/00365521.2022.2041717] [Reference Citation Analysis]
12 Hu S, Zhao X, Qian F, Jin C, Hou K. Correlation between LRP1B Mutations and Tumor Mutation Burden in Gastric Cancer. Comput Math Methods Med 2021;2021:1522250. [PMID: 34603481 DOI: 10.1155/2021/1522250] [Reference Citation Analysis]
13 Fujiya K, Terashima M, Ohshima K, Aizawa D, Sugino T, Serizawa M, Nakamura K, Nagashima T, Hatakeyama K, Urakami K, Akiyama Y, Tsubosa Y, Kitagawa Y, Yamaguchi K. MAGEA10 expression is a predictive marker of early hepatic recurrence after curative gastrectomy for gastric and gastroesophageal junction cancer. Gastric Cancer 2021;24:341-51. [PMID: 32965606 DOI: 10.1007/s10120-020-01123-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Jung JO, Nienhüser H, Schleussner N, Schmidt T. Oligometastatic Gastroesophageal Adenocarcinoma: Molecular Pathophysiology and Current Therapeutic Approach. Int J Mol Sci 2020;21:E951. [PMID: 32023907 DOI: 10.3390/ijms21030951] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]